Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Xtl Biopharmaceuticals Ltd Is An Intellectual Property-Based Company Focused On The Development, Management, And Commercialization Of Intellectual Property. The Company Is Engaged In Biotechnology Through Its Subsidiary Psyga Bio And In The Biopharmaceutical Industry With Hcdr1, A Novel Compound Working Via A Novel Mechanism Of Action For The Treatment Of Systemic Lupus Erythematosus (Sle) And A Potential Treatment For Sjogren'S Syndrome (Ss). It Focuses On The Acquisition And Development Of Proprietary Products And Late-Stage Pharmaceutical Product Candidates For The Treatment Of Unmet Clinical Needs.